C3 Biotechnologies Limited
09620994
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
30/09/2025
small
Next accounts due
30/06/2027
Confirmation statement
Last: 03/06/2026
Due 17/06/2027
Industry
Officers
Mr Michael Hyde Smith
director · Since 02/07/2026
BRITISH · UNITED KINGDOM · Age 68
Former
director · Resigned 24/06/2026
secretary · Resigned 25/06/2026
director · Resigned 02/07/2026
Persons with Significant Control
Professor Nigel Scrutton
British · United Kingdom · Age 62
28 Chardin Avenue, Marple Bridge, SK6 5DN
Notified 04/06/2016
Former PSCs
Mr Michael Hyde Smith
Ceased 01/07/2026
Professor Nigel Shaun Scrutton
Ceased 25/04/2016
Mr Michael Hyde Smith
Ceased 01/07/2026
CompanyRankvs 899+ SIC 72110 peers68
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/09/2025
Net Worth
£406k
Balance sheet strength
Cash
£97k
Cash in the bank
Net Current Assets
-£37k
Working capital
Current Assets
£148k
Current Liabilities
£185k
Fixed Assets
£443k
Debtors
£51k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.80 | -£36k |
| 2024 | 0.97 | -£148k |
| 2023 | 2.35 | — |
Derived from filed accounts. Not audited figures.